Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-060679
Filing Date
2013-11-26
Accepted
2013-11-26 13:26:11
Documents
1
Period of Report
2013-11-26

Document Format Files

Seq Description Document Type Size
1 FC OPENMARKETPURCHASE 11-26-13 rrd396309.html 4  
1 FC OPENMARKETPURCHASE 11-26-13 rrd396309.xml 4 3452
  Complete submission text file 0001181431-13-060679.txt   4852
Mailing Address 4 LIBERTY SQUARE 4TH FLOOR BOSTON MA 02109
Business Address 4 LIBERTY SQUARE 4TH FLOOR BOSTON MA 02109 973-486-8820
COLUMBIA LABORATORIES INC (Issuer) CIK: 0000821995 (see all company filings)

EIN.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 354 EISENHOWER PARKWAY PLAZA I - SECOND FLOOR LIVINGSTON NJ 07039
Business Address
CONDELLA FRANK JR (Reporting) CIK: 0001282199 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-10352 | Film No.: 131243388